BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Oxprenolol

A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.

300+ PubMed studies analyzed · 70 RCTs · Evidence Score: 53.5

Research Domains

Oxprenolol has been studied across 18 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🧘 Stress & Anxiety, 😴 Sleep, 🫘 Kidney. The primary research focus is ❤️ Cardiovascular with 44% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Oxprenolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Carteolol
3 shared targets
Celiprolol
3 shared targets
cgp
2 shared targets
Xamoterol
2 shared targets
Acebutolol
3 shared targets
zenidolol
2 shared targets
levisoprenaline
2 shared targets
l
2 shared targets
l
2 shared targets
Bisoprolol
2 shared targets
Loading evidence profile...

This evidence profile for Oxprenolol is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.